BBusiness Read More FDA approves Signos glucose monitoring for weight lossAugust 20, 2025 Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever…
HHealth Read More New study casts doubts on RFK Jr.’s reasons for gutting vaccine panelAugust 19, 2025 U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. speaks as he attends a press conference…
BBusiness Read More FDA may pull authorization of Pfizer Covid shot for children under 5August 13, 2025 A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in…
BBusiness Read More Trump says pharma tariffs could eventually reach up to 250%August 5, 2025 U.S. President Donald Trump talks to members of the press at Lehigh Valley International Airport in Allentown, Pennsylvania,…
BBusiness Read More Moderna (MRNA) Q2 2025 earningsAugust 1, 2025 Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images…
BBusiness Read More Moderna to slash 10% of workforce amid Covid vaccine salesJuly 31, 2025 The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images…
BBusiness Read More UnitedHealth Group (UNH) earnings report Q2 2025July 29, 2025 UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s…
BBusiness Read More UnitedHealth facing DOJ investigation over Medicare billingJuly 24, 2025 UnitedHealth Group revealed Thursday it is facing a Department of Justice investigation over its Medicare billing practices, adding…
HHealth Read More Researchers move closer to a universal cancer vaccineJuly 24, 2025 Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…
HHealth Read More Weight loss drugs could help treat PCOSJuly 20, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
BBusiness Read More Sarepta stock falls on FDA gene therapy Elevidys commentJuly 18, 2025 Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…
MMedication Read More FDA to consider drug affordability when speeding up approvals: MakaryJuly 11, 2025 The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals…